| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
2 companies
Dominic Piscitelli is Chief Financial Officer at ORIC, with reported holdings spanning 2 companies. From December 2018 to October 2026, the filings on record show 1 open-market purchase and 16 sales. Dominic Piscitelli's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $670K at current prices.
Our model assigns Dominic Piscitelli a middling insider score of 64/100, based on 15 past trades. Over a 12-month horizon, 84.6% of those trades were profitable, with an average 12-month return of +3.5%.
Dominic Piscitelli's largest disclosed position is in ORIC as Chief Financial Officer, worth about $670K. The ORIC filings lean toward selling, a net 194,942 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 11, 2025 | ORIC Oric Pharmaceuticals, Inc. | Chief Financial Officer | Sell10b5-1 | 3,300 | $10.01 | $33,017.00 | -3.1% | +16.2% | -16.7% | |
| Jun 9, 2025 | ORIC Oric Pharmaceuticals, Inc. | Chief Financial Officer | Sell10b5-1 | 2,900 | $10.01 | $29,021.32 | -2.7% | +6.5% | -18.9% | |
| Dec 16, 2024 | ORIC Oric Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 8,851 | $8.28 | $73,297.79 | -7.7% | -4.0% | +10.7% | |
| Dec 15, 2023 | ORIC Oric Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 5,282 | $8.58 | $45,338.05 | -5.9% | +61.3% | -8.5% | |
| Dec 15, 2022 | ORIC Oric Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 2,089 | $3.25 | $6,789.25 | -3.0% | +33.2% | +186.5% | |
| Mar 31, 2022 | ORIC Oric Pharmaceuticals, Inc. | Chief Financial Officer | Buy | 60,000 | $5.36 | $321,624.00 | New | -15.7% | +6.7% | |
| Dec 3, 2018 | ANAB Anaptysbio, Inc | Chief Financial Officer | Sale+OE | 37,000 | $72.14 | $2,669,157.50 | - | - | - |